GHIT Fund Announces New Investments: A Total of Approximately 260 Million Yen in Shionogi, Takeda Pharmaceutical for New Malaria Drug Development

/PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment totaling approximately 260 million yen (US$1.9 million1) for...

Related Keywords

Nagasaki ,Yamagata ,Japan ,Tokyo ,Japanese ,Osamu Kunii ,Eriko Mugitani ,Katy Lenard ,United Nations Development Programme ,Nagasaki University ,Shionogi Co Ltd ,World Health Organization ,Daiichi Sankyo Rd Novare Co Ltd ,Melinda Gates Foundation ,Takeda Pharmaceutical Company ,Tb Drug Development Alliance ,Global Health Innovative Technology ,Tb Alliance ,Global Alliance ,Takeda Pharmaceutical Company Limited ,Wellcome ,Malaria Venture ,Takeda Pharmaceutical ,Daiichi Sankyo ,Screening Platform ,Hit To Lead Platform ,Pharmaceutical Company Limited ,Health Innovative Technology ,Global Health Innovative Technology Ghit Fund ,